Adding abiraterone to standard treatment improves prostate cancer survival by 40 per cent

Via Men's Health News From Medical News Today

Adding abiraterone to hormone therapy at the start of treatment for prostate cancer improves survival by 37 per cent, according to the results of one of the largest ever clinical trials for prostate...

View original post here:

%d bloggers like this: